Oxymetholon 50mg

Dragon Pharma Oxymetholon — Anadrol 50mg Mass Accelerator

Dragon Pharma Oxymetholon delivers 50 mg of Oxymetholone per tablet. This legendary oral agent is engineered for athletes pursuing explosive hypertrophy and immediate strength surges.

Commonly known as Anadrol or "A-Bombs," this C17-alpha alkylated compound produces dramatic weight accretion within the first few weeks of administration. Each batch is manufactured under rigorous quality protocols and verified by independent laboratory analysis.

Overview

Oxymetholone is a synthetic DHT-derived anabolic steroid with a 2-hydroxymethylene group modification. This structural alteration delivers exceptional anabolic potency alongside significant progestogenic and estrogenic activity.

The compound rapidly stimulates erythropoiesis, enhancing oxygen-carrying capacity and muscular endurance. Users frequently report a pronounced sense of well-being and heightened training aggression during the active phase.

Unlike dry cutting agents, Oxymetholon generates substantial intracellular fluid and glycogen retention. This produces a perpetually full, volumized appearance even outside the gym.

Dragon Pharma subjects every production lot to third-party analytical testing. Recent assays confirm tablet potency consistently aligns with the labeled 50 mg specification, ensuring predictable pharmacological outcomes.

Benefits

• Rapid Mass Accretion: Facilitates 10–20 pounds of scale weight within a 4–6 week protocol, driven by intense intramuscular hydration and protein synthesis.
• Explosive Strength Surges: Dramatically increases power output within days, enabling heavier compound lifts and greater training density.
• Enhanced Muscular Endurance: Stimulates red blood cell production and hemoglobin synthesis, improving oxygen delivery and delaying fatigue.
• Accelerated Recovery: Supports faster tissue repair between sessions, allowing for increased training frequency and volume.
• Immediate Anabolic Environment: Functions as a powerful cycle kickstarter while longer-estered injectable compounds reach steady-state concentrations.

Main Features

• Precisely dosed 50 mg oral tablets for flexible titration
• Synthetic dihydrotestosterone derivative with 2-hydroxymethylene modification
• High anabolic activity with significant estrogenic and progestogenic properties
• C17-alpha alkylated formulation for oral bioavailability
• Rapid onset of action ideal for frontloading bulking cycles
• Independent laboratory verification of concentration and purity

Ingredients

Each tablet contains 50 mg of Oxymetholone as the active pharmaceutical ingredient.

Inactive excipients include microcrystalline cellulose, magnesium stearate, and pharmaceutical-grade binders to ensure tablet hardness, stability, and consistent dissolution characteristics.

All raw materials undergo identity and purity validation prior to compression and coating.

How to Use

Ingest tablets with food to minimize gastrointestinal irritation. Splitting the daily total into morning and evening administrations maintains stable plasma levels.

Store the container in a cool, dry environment away from direct light and moisture. Keep the desiccant pouch intact to preserve tablet integrity.

Dosage

Beginners should initiate at 50 mg daily, administered as a single tablet. This allows for assessment of individual tolerance and estrogenic response.

Intermediate users may escalate to 100 mg daily, divided into two 50 mg doses. Do not exceed this threshold, as adverse effects escalate disproportionately beyond this point.

Limit continuous administration to 4–6 weeks maximum. The hepatotoxic burden accumulates rapidly, and extended exposure significantly increases hepatic risk.

Side Effects

Estrogenic manifestations are prominent. Users frequently experience significant water retention, peripheral edema, elevated blood pressure, and gynecomastia. Proactive aromatase inhibitor use is essential from day one.

Hepatotoxicity is severe due to C17-alpha alkylation. Liver enzyme elevations are common even at moderate doses. Hepatoprotective agents such as TUDCA and N-acetylcysteine are mandatory.

Androgenic sequelae include acne vulgaris, accelerated scalp hair thinning in predisposed individuals, and increased sebum production.

The compound exerts a profound suppressive effect on the hypothalamic-pituitary-gonadal axis. Endogenous testosterone production declines rapidly, making structured Post-Cycle Therapy absolutely critical.

Cardiovascular strain is significant. Oxymetholone typically suppresses HDL cholesterol while elevating LDL. Regular lipid panels and heart-healthy dietary practices are required.

Other reported effects include headaches, appetite fluctuations, and general lethargy in some individuals.

Safety Information

This product is intended exclusively for research purposes and use by qualified male adults. It is not suitable for minors, women, or individuals with hepatic, cardiovascular, or renal conditions.

Aromatase inhibitor therapy must begin concurrently with the first dose. Blood pressure monitoring should occur at regular intervals throughout the cycle.

Comprehensive liver support supplementation is non-negotiable. Avoid alcohol, acetaminophen, and all other hepatotoxic substances during the active phase.

A structured PCT protocol using Clomiphene or Tamoxifen must follow cycle cessation. This restores natural testosterone synthesis and preserves accrued tissue.

Maintain a diet low in saturated fats and rich in omega-3 fatty acids. Regular cardiovascular exercise supports lipid management and vascular health.

Discontinue immediately and seek medical evaluation if jaundice, severe abdominal pain, dark urine, or persistent nausea develop.